Stay in Touch
To keep in touch, please sign up to the Milltrust Ventures Newsletter for our latest news and insights.
BBC Spotlight interview Professor Andrew Shaw, Founder & CEO of Attomarker, a company backed by Milltrust, and Robert W. Badcock, CEO Mantracourt Electronics on their collaboration of the world’s first rapid point-of-care quantitative test revealing whether your antibody levels are above or below a threshold of protection.
Contact us for more information on Attomarker’s current Acceleration funding round.
Categories: News